ESC 365 - The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients

ESC Premium Access

The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients

Session: Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome

Topic: Epidemiology, Prognosis, Outcome

Speaker: Mr D. Ayoubkhani (Cardiff, GB)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Daniel Ayoubkhani

Health Economics & Outcomes Research Ltd, Cardiff (United Kingdom of Great Britain & Northern Ireland)

0 follower

16 more presentations in this session

Longitudinal changes in troponin concentrations from mid- to late-life and left ventricular structure and function in late-life: The Atherosclerosis Risk in Community Study

Speaker: Doctor P. Myhre (Nordbyhagen, NO)

One year follow-up of heart failure patients: role of the new TNM-like staging system

Speaker: Doctor M. Alfarano (Rome, IT)

Incidence and prevalence of light chain amyloidosis: a population-based study

Speaker: Miss S. Duhamel (Bron, FR)

Deaths and vascular outcomes with non-vitamin k oral anticoagulants versus warfarin in patients with heart failure in the food and drug administration adverse event reporting system

Speaker: Doctor T. Von Lueder (Oslo, NO)

Prediction of sudden death in outpatients with heart failure: a bio-clinical approach.

Speaker: Doctor J. Lupon (Barcelona, ES)

Access the full session

Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome

Speakers: Mr D. Ayoubkhani, Doctor P. Myhre, Doctor M. Alfarano, Miss S. Duhamel, Doctor T. Von Lueder...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources